1. Home
  2. CRIS vs KPLT Comparison

CRIS vs KPLT Comparison

Compare CRIS & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • KPLT
  • Stock Information
  • Founded
  • CRIS 2000
  • KPLT 2012
  • Country
  • CRIS United States
  • KPLT United States
  • Employees
  • CRIS N/A
  • KPLT N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • KPLT Diversified Commercial Services
  • Sector
  • CRIS Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • CRIS 21.3M
  • KPLT 34.2M
  • IPO Year
  • CRIS 2000
  • KPLT N/A
  • Fundamental
  • Price
  • CRIS $1.88
  • KPLT $7.89
  • Analyst Decision
  • CRIS Strong Buy
  • KPLT Hold
  • Analyst Count
  • CRIS 2
  • KPLT 2
  • Target Price
  • CRIS $16.50
  • KPLT $12.00
  • AVG Volume (30 Days)
  • CRIS 153.9K
  • KPLT 24.4K
  • Earning Date
  • CRIS 07-31-2025
  • KPLT 08-13-2025
  • Dividend Yield
  • CRIS N/A
  • KPLT N/A
  • EPS Growth
  • CRIS N/A
  • KPLT N/A
  • EPS
  • CRIS N/A
  • KPLT N/A
  • Revenue
  • CRIS $11,202,000.00
  • KPLT $254,079,000.00
  • Revenue This Year
  • CRIS N/A
  • KPLT $22.26
  • Revenue Next Year
  • CRIS $10.67
  • KPLT $11.03
  • P/E Ratio
  • CRIS N/A
  • KPLT N/A
  • Revenue Growth
  • CRIS 14.17
  • KPLT 9.72
  • 52 Week Low
  • CRIS $1.02
  • KPLT $5.08
  • 52 Week High
  • CRIS $8.29
  • KPLT $21.88
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 41.14
  • KPLT 44.55
  • Support Level
  • CRIS $1.50
  • KPLT $7.45
  • Resistance Level
  • CRIS $1.90
  • KPLT $8.44
  • Average True Range (ATR)
  • CRIS 0.20
  • KPLT 0.60
  • MACD
  • CRIS -0.06
  • KPLT -0.04
  • Stochastic Oscillator
  • CRIS 35.51
  • KPLT 37.11

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: